Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.

Autor: Patel MA; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA., Shah JL; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA., Brinley FJ 4th; Bio-techne: ProteinSimple Inc, San Jose, California, USA., Abrahamse PH; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA., Veenstra CM; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA., Schott AF; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.

Publikováno v: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (11), pp. 12802-12812. Date of Electronic Publication: 2023 May 07.